BBP

BBP
About Virtus Biotech ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
About Virtus Biotech ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
IBRX | ImmunityBio, Inc. | 6.06% | 323.31K | $3.09M |
MRNA | Moderna, Inc. | 2.63% | 25.90K | $1.34M |
IOVA | Iovance Biotherapeutics, Inc. | 2.58% | 346.83K | $1.31M |
NVAX | Novavax, Inc. | 2.55% | 116.14K | $1.30M |
MIRM | Mirum Pharmaceuticals, Inc. | 2.12% | 11.74K | $1.08M |
FOLD | Amicus Therapeutics, Inc. | 2.03% | 72.32K | $1.04M |
ROIV | Roivant Sciences Ltd. | 1.93% | 34.53K | $983.64K |
DAWN | Day One Biopharmaceuticals, Inc. | 1.91% | 91.27K | $972.02K |
GERN | Geron Corporation | 1.82% | 561.04K | $925.72K |
GILD | Gilead Sciences, Inc. | 1.79% | 6.34K | $911.07K |
AMGN | Amgen Inc. | 1.79% | 2.40K | $910.77K |
BMRN | BioMarin Pharmaceutical Inc. | 1.72% | 14.31K | $874.61K |
BNTX | BioNTech SE | 1.72% | 8.05K | $875.51K |
KRYS | Krystal Biotech, Inc. | 1.69% | 3.12K | $861.69K |
HALO | Halozyme Therapeutics, Inc. | 1.67% | 12.27K | $848.98K |
ZLAB | Zai Lab Limited | 1.66% | 42.94K | $845.47K |
AXSM | Axsome Therapeutics, Inc. | 1.65% | 5.15K | $840.43K |
AGIO | Agios Pharmaceuticals, Inc. | 1.65% | 27.98K | $838.84K |
CRSP | CRISPR Therapeutics AG | 1.63% | 13.46K | $831.14K |
EXEL | Exelixis, Inc. | 1.62% | 18.66K | $826.49K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
IBRX
ImmunityBio, Inc.
MRNA
Moderna, Inc.
IOVA
Iovance Biotherapeutics, Inc.
NVAX
Novavax, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
FOLD
Amicus Therapeutics, Inc.
ROIV
Roivant Sciences Ltd.
DAWN
Day One Biopharmaceuticals, Inc.
GERN
Geron Corporation
GILD
Gilead Sciences, Inc.
AMGN
Amgen Inc.
BMRN
BioMarin Pharmaceutical Inc.
BNTX
BioNTech SE
KRYS
Krystal Biotech, Inc.
HALO
Halozyme Therapeutics, Inc.
ZLAB
Zai Lab Limited
AXSM
Axsome Therapeutics, Inc.
AGIO
Agios Pharmaceuticals, Inc.
CRSP
CRISPR Therapeutics AG
EXEL
Exelixis, Inc.
